Somatostatin analogs in the diagnosis and treatment of cancer.
about
Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton InvolvementLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaSomatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Somatostatin and cancer: applying endocrinology to oncology.Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activityNovel synthesis of various orthogonally protected Cα-methyllysine analogues and biological evaluation of a vapreotide analogue containing (S)-α-methyllysine.Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer.Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case reportThe effect of co-administration of Lawsonia inermis extract and octreotide on experimental hepatocellular carcinomaIdentification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.Ageing and metabolism: drug discovery opportunities.Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.Somatostatin receptor scintigraphy in thoracic diseases.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy.Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin ReceptorsThe treatment of hyperinsulinemic hypoglycaemia in adults: an update.Imaging and therapy of hSSTR2-transfected tumors using radiolabeled somatostatin analogs.Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization.Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude miceThe somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.Somatostatin analogues labeled with copper radioisotopes: current status.Advanced neuroimaging studies in a patient with brain metastases from transitional cell carcinoma of the bladder.Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
P2860
Q26770701-74E73E09-0811-413A-855D-D72721D0B084Q28068437-FCBBB734-EE24-495B-8008-5E29DE414460Q30274979-93318303-AF0A-4904-83A4-3172F271F02CQ33753449-6EB26349-CCDF-4497-9192-F438E02ADDB1Q34181921-E5532866-9AB6-4FB7-A37C-6E1B1D87C065Q34832716-AA1DEA95-A30E-468E-9926-0964B967F0D3Q34940355-5ABB8F3E-08B9-48C6-804D-5FC821EA5917Q35130509-94E8D801-7104-491A-99E1-9A8F8AF400EDQ35478306-52AB0DD4-3571-4C0E-B001-244C6E49C0CEQ35614440-C3815135-FFDD-4EBC-B59C-B03D2E13BD15Q35986032-F6BEF3D0-E3CF-4E93-AB09-FA2E45761EFBQ36174012-DF01B873-3B1A-4E70-83EB-E35D6AF7CC95Q36541304-75E97352-6053-4BDC-B68F-427C925381B0Q36916282-0288C6A5-4ECE-47C1-91D5-32F2156A5749Q37030460-385D5209-49FD-4590-BD3B-6E055F4374B3Q37236103-B73D6259-D796-495B-8B12-1BB2783CCAB8Q37564373-0EBC1053-29E5-40B1-BD6C-7C2DF35C5F50Q38007182-EDDF03F4-8688-4828-9150-23D6D67331A7Q38166623-94B3E9CA-932D-42A0-90B4-A46E220066C3Q38953515-A6DAF455-9A1F-47ED-9028-B6BD592BB66CQ39162740-E6A6CEB9-3660-4FF2-94A1-A526C9BA0E12Q39957511-00ADB7C8-B823-4963-B4AE-4CE0588890A0Q40403100-5F4ECC58-215A-4933-9D90-68A0A17A2FF3Q41933915-E0792BA7-086F-41CE-8C62-4646A4B518AFQ42133416-B31373CB-FF80-45A2-8623-7C946F535C9EQ45875843-F97C422D-462F-48DA-885B-6CCEC740A2A3Q46614069-047A6A1F-8987-4651-AA49-ADC42F1F08AEQ48476082-C906C35E-B7A9-48BE-8C3E-1CB0786B56E0Q49352143-E69D4BA6-1C0F-45A5-8D9C-23F8E7672B8B
P2860
Somatostatin analogs in the diagnosis and treatment of cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Somatostatin analogs in the diagnosis and treatment of cancer.
@ast
Somatostatin analogs in the diagnosis and treatment of cancer.
@en
Somatostatin analogs in the diagnosis and treatment of cancer.
@nl
type
label
Somatostatin analogs in the diagnosis and treatment of cancer.
@ast
Somatostatin analogs in the diagnosis and treatment of cancer.
@en
Somatostatin analogs in the diagnosis and treatment of cancer.
@nl
prefLabel
Somatostatin analogs in the diagnosis and treatment of cancer.
@ast
Somatostatin analogs in the diagnosis and treatment of cancer.
@en
Somatostatin analogs in the diagnosis and treatment of cancer.
@nl
P1476
Somatostatin analogs in the diagnosis and treatment of cancer.
@en
P2093
Leo J Hofland
Steven W J Lamberts
P304
P356
10.1016/S1043-2760(02)00667-7
P577
2002-12-01T00:00:00Z